Nonalcoholic Fatty Liver Disease Is Associated with the Presence and Morphology of Subclinical Coronary Atherosclerosis

키워드

참고문헌 (29)

1. Hsiao TJ, "Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients", Int J Obes Relat Metab Disord, 28, pp.167~172 (2004)
2. Suzuki A, "Chronological development of elevated aminotransferases in a nonalcoholic population", Hepatology, 41, pp.64~71 (2005)
3. Bedogni G, "Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study", Hepatology, 42, pp.44~52 (2005)
4. Chen CH, "Association between nonalcoholic fatty liver disease and coronary artery calcification", Dig Dis Sci, 55, pp.1752~1760 (2010)
5. Adams LA, "The natural history of nonalcoholic fatty liver disease:a population-based cohort study", Gastroenterology, 129, pp.113~121 (2005)
6. Adibi P, "Prediction of coronary atherosclerotic disease with liver transaminase level", Liver Int, 27, pp.895~900 (2007)
7. Hoffmann U, "Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography", J Am Coll Cardiol, 47, pp.1655~1662 (2006)
8. Abdulla J, "Prognostic value of absence or presence of coronary artery disease determined by 64-slice computed tomography coronary angiography a systematic review and metaanalysis", Int J Cardiovasc Imaging, 27, pp.413~420 (2011)
9. Bamberg F, "Association between cardiovascular risk profiles and the presence and extent of different types of coronary atherosclerotic plaque as detected by multidetector computed tomography", Arterioscler Thromb Vasc Biol, 28, pp.568~574 (2008)
10. National Cholesterol Education Program (NCEP) Expert Panel on Detection, "Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report", Circulation, 106, pp.3143~3421 (2002)
11. Osawa H, "Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes", J Clin Ultrasound, 24, pp.25~29 (1996)
12. el-Hassan AY, "Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management", Br J Radiol, 65, pp.774~778 (1992)
13. Austen WG, "A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association", Circulation, 51(4 Suppl), pp.5~40 (1975)
14. Agatston AS, "Quantification of coronary artery calcium using ultrafast computed tomography", J Am Coll Cardiol, 15, pp.827~832 (1990)
15. Ekstedt M, "Long-term follow-up of patients with NAFLD and elevated liver enzymes", Hepatology, 44, pp.865~873 (2006)
16. Hamaguchi M, "Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease", World J Gastroenterol, 13, pp.1579~1584 (2007)
17. Pearson TA, "Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association", Circulation, 107, pp.499~511 (2003)
18. Pai JK, "Inflammatory markers and the risk of coronary heart disease in men and women", N Engl J Med, 351, pp.2599~2610 (2004)
19. Lizardi-Cervera J, "Association among C-reactive protein, Fatty liver disease, and cardiovascular risk", Dig Dis Sci, 52, pp.2375~2379 (2007)
20. Rydén M, "Tumour necrosis factor-alpha in human adipose tissue--from signalling mechanisms to clinical implications", J Intern Med, 262, pp.431~438 (2007)
21. Gupta D, "Long-term effects of tumor necrosis factor-alpha treatment on insulin signaling pathway in HepG2 cells and HepG2 cells overexpressing constitutively active Akt", PKB, 2007, pp.100, 593~607
22. Corti R, "Pathogenetic concepts of acute coronary syndromes", J Am Coll Cardiol, 41(4 Suppl S), pp.7S~14S (2003)
23. Davignon J, "Role of endothelial dysfunction in atherosclerosis", Circulation, 109(23 Suppl 1), pp.III27~III32 (2004)
24. Villanova N, "Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease", Hepatology, 42, pp.473~480 (2005)
25. Targher G, "Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation", Diabetes Care, 27, pp.2498~2500 (2004)
26. Brea A, "Nonalcoholic fatty liver disease is associated with carotid atherosclerosis:a case-control study", Arterioscler Thromb Vasc Biol, 25, pp.1045~1050 (2005)
27. Targher G, "Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients", J Endocrinol Invest, 29, pp.55~60 (2006)
28. Fracanzani AL, "Carotid artery intima-media thickness in nonalcoholic fatty liver disease", Am J Med, 121, pp.72~78 (2008)
29. Wong VW, "Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease", Gut, 60, pp.1721~1727 (2011)

관련 논문AI추천